Clinical Trials Browser

HER-2 Negative Breast Cancer × Bevacizumab × Clear all

NCT05398861 2022-06-01

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

Phase 2 Unknown

HER-2 Negative Breast Cancer